Skip to main content
Top
Published in: Neurological Sciences 9/2022

31-05-2022 | Autoimmune Encephalitis | Review Article

Autoimmune encephalitis and CSF anti-AMPA GluR3 antibodies in childhood: a case report and literature review

Authors: Maria Elena Cucuzza, Piero Pavone, Angela D’Ambra, Maria Carla Finocchiaro, Filippo Greco, Pierluigi Smilari, Martino Ruggieri, Vita Antonella Di Stefano

Published in: Neurological Sciences | Issue 9/2022

Login to get access

Abstract

Acute autoimmune encephalitis is a severe neurological disorder presenting with altered level of consciousness, confusion, irritability, headache, vomiting, and in some cases seizures. An infective event precedes by 1–2 weeks the onset of the symptoms. Cognitive impairment is considered the cardinal symptom. The autoimmune encephalitis comprises an increasingly group of inflammatory brain disorder caused by an underlying abnormal immune response to the CNS to the infective agent. In children, several antibodies have been recorded as causative agent. Among these, GAD65, MOG, and NMDAR antibodies are more commonly reported and with less frequency, the Dopamine-2 receptor, GABA A receptor, GABA B receptor, and Glycinereceptorandm-GluR5. We report here a 10-year-old male with acute autoimmune encephalitis with altered status of consciousness and severe cerebral involvement at the brain-MRI. Serum and cerebrospinal fluid disclosed the presence of anti-AMPA-GluR3 antibodies suggesting a possible pathogenetic correlation with the disorder presented by the proband. Precocious treatment with intravenous methylprednisolone and immunoglobulin resulted in progressive but constant improvement. At 3-month follow-up, the clinical condition of the child and the neuro-radiological brain anomalies returned to the normal. At the 2-year follow-up, no recurrence or other disturbances were reported.
Literature
1.
go back to reference Said S, Kang M (2021) Viral encephalitis. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing Said S, Kang M (2021) Viral encephalitis. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing
2.
go back to reference Erickson T, Musca l, Munoz F et al (2020) Infectious and autoimmune causes of encephalitis in children. Pediatrics 145(6) Erickson T, Musca l, Munoz F et al (2020) Infectious and autoimmune causes of encephalitis in children. Pediatrics 145(6)
3.
go back to reference Dubey D, Pittock S, Krecke K et al (2019) Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 76(3):301–309CrossRef Dubey D, Pittock S, Krecke K et al (2019) Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 76(3):301–309CrossRef
4.
go back to reference de Bruijn M, Bruijstens A, Bastiaansen A et al (2020) Pediatric autoimmune encephalitis: recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm 7(3):e682CrossRef de Bruijn M, Bruijstens A, Bastiaansen A et al (2020) Pediatric autoimmune encephalitis: recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm 7(3):e682CrossRef
5.
go back to reference Cellucci T, Van Mater H, Graus F et al (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm 7(2):e663CrossRef Cellucci T, Van Mater H, Graus F et al (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm 7(2):e663CrossRef
6.
go back to reference Dutra L, Abrantes F, Toso F et al (2018) Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 76(1):41–49CrossRef Dutra L, Abrantes F, Toso F et al (2018) Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 76(1):41–49CrossRef
7.
go back to reference Abboud H, Probasco J, Irani S et al (2021) Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92(7):757–768CrossRef Abboud H, Probasco J, Irani S et al (2021) Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92(7):757–768CrossRef
8.
go back to reference Hacohen Y, Wright S, Waters P et al (2013) Paediatric autoimmune encephalopathies: clinical features, laboratory investigation sand out comesin patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 84(7):748–55CrossRef Hacohen Y, Wright S, Waters P et al (2013) Paediatric autoimmune encephalopathies: clinical features, laboratory investigation sand out comesin patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 84(7):748–55CrossRef
9.
go back to reference Levite M (2014) Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies oranti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren’s syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor’s expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. J NeuralTransm 121(8):1029–75 Levite M (2014) Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies oranti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren’s syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor’s expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. J NeuralTransm 121(8):1029–75
10.
go back to reference Spatola M, Pedrol M, Maudes E et al (2020) Clinical features, prognostic factors, and antibody effects in anti-mGluR1encephalitis. Neurology 95(22):e3012–e3025CrossRef Spatola M, Pedrol M, Maudes E et al (2020) Clinical features, prognostic factors, and antibody effects in anti-mGluR1encephalitis. Neurology 95(22):e3012–e3025CrossRef
11.
go back to reference Lancaster E, Martinez-Hernandez E, Titulaer M (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77(18):1698–1701CrossRef Lancaster E, Martinez-Hernandez E, Titulaer M (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77(18):1698–1701CrossRef
12.
go back to reference Guevara C, Farias G, Silva-Rosas C et al (2018) Encephalitis associated to metabotropic glutamate receptor 5 (mGluR5) antibodies in cerebrospinal fluid. Front Immunol 9:2568CrossRef Guevara C, Farias G, Silva-Rosas C et al (2018) Encephalitis associated to metabotropic glutamate receptor 5 (mGluR5) antibodies in cerebrospinal fluid. Front Immunol 9:2568CrossRef
13.
go back to reference Scherer S, Duvoisin R, Kuhn R et al (1996) Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics 31(2):230–233CrossRef Scherer S, Duvoisin R, Kuhn R et al (1996) Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics 31(2):230–233CrossRef
14.
go back to reference Saini S, Mancuso S, Mostaid S et al (2017) Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Transl Psychiatry7(8) Saini S, Mancuso S, Mostaid S et al (2017) Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Transl Psychiatry7(8)
15.
go back to reference Fromer M, Pocklington AJ, Kavanagh DH et al (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179–84CrossRef Fromer M, Pocklington AJ, Kavanagh DH et al (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179–84CrossRef
16.
go back to reference Kandaswamy R, McQuillin A, Sharp SI et al (2013) Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 70(6):591–8CrossRef Kandaswamy R, McQuillin A, Sharp SI et al (2013) Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 70(6):591–8CrossRef
17.
go back to reference Mantegazza R, Bernasconi P, Baggi F et al (2002) Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131(1–2):179–185CrossRef Mantegazza R, Bernasconi P, Baggi F et al (2002) Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131(1–2):179–185CrossRef
18.
go back to reference Buscarinu M, Fornasiero A, Pellicciari G et al (2019) Autoimmune encephalitis and CSF anti-GluR3 antibodies in an MS patient after alemtuzumab Buscarinu M, Fornasiero A, Pellicciari G et al (2019) Autoimmune encephalitis and CSF anti-GluR3 antibodies in an MS patient after alemtuzumab
Metadata
Title
Autoimmune encephalitis and CSF anti-AMPA GluR3 antibodies in childhood: a case report and literature review
Authors
Maria Elena Cucuzza
Piero Pavone
Angela D’Ambra
Maria Carla Finocchiaro
Filippo Greco
Pierluigi Smilari
Martino Ruggieri
Vita Antonella Di Stefano
Publication date
31-05-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06170-0

Other articles of this Issue 9/2022

Neurological Sciences 9/2022 Go to the issue